QNCX Quince Therapeutics Inc

Price (delayed)

$30.15

Market cap

$30.66M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$142.31

Enterprise value

-$85.32M

?
Relative Growth: Rel. Growth: 12
Relative Strength: Rel. Strength: 40
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0

Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer’s and other degenerative diseases. Based upon the evidence ...

Highlights
The quick ratio has soared by 193% YoY
The debt has shrunk by 100% QoQ and by 100% YoY
The net income has shrunk by 180% QoQ and by 89% YoY

Key stats

What are the main financial stats of QNCX

QNCX stock price

How has the Quince Therapeutics stock price performed over time
Intraday
-3.83%
1 week
10.97%
1 month
-11.14%
1 year
-90.64%
YTD
-95.5%
QTD
65.75%

Financial performance

How have Quince Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$186.3M
Net income
-$92.48M
Gross margin
N/A
Net margin
N/A
The net income has shrunk by 180% QoQ and by 89% YoY
QNCX's operating income has dropped by 60% since the previous quarter

Price vs fundamentals

How does QNCX's price correlate with its fundamentals

Growth

What is Quince Therapeutics's growth rate over time

Valuation

What is Quince Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 35% year-on-year and by 28% since the previous quarter

Efficiency

How efficient is Quince Therapeutics business performance
Quince Therapeutics's ROA has plunged by 174% from the previous quarter and by 148% YoY

Dividends

What is QNCX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QNCX.

Financial health

How did Quince Therapeutics financials performed over time
The quick ratio has soared by 193% YoY
The current ratio has soared by 190% YoY
The debt is 100% higher than the equity
The debt has shrunk by 100% QoQ and by 100% YoY
QNCX's debt to equity has dropped by 100% since the previous quarter and by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.